Modern Water Q2 orders exceed £3m post COVID restrictions in China & South Asia
Deepverge PLC (AIM:DVRG) Modern Water Q2 orders exceed £3m, RPT
Deepverge PLC (AIM:DVRG) Final Results for the year ended 31 December 2021
Revenue grew 107% to £9.3m
Vela Technologies (AIM:VELA) Statement re. potential investment in TruSpine
The Board of Vela (AIM:VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, announces that, on Friday 10 June 2022, the Company became aware of a
Deepverge Attends The UK Global Investor Show 2022 in London last weekend
A team from Deepverge presented at the UK Global Investor Show 2022 in London last weekend. Gerard Brandon, CEO, Camillus Glover, CFO, Paul Ryan, Chief Business Development Officer and Nicola
Futura Medical PLC (AIM:FUM) MED3000 Collaboration in EEA, UK & Switzerland
Futura Announces Collaboration with Cooper Consumer Health to Commercialise MED3000 in EEA, United Kingdom and Switzerland
Catenae Innovation (AIM:CTEA) Further re:- Suspension of Trading on AIM
Further to the Company’s announcement of 23 March 2022, the Company advises that it continues to work to complete the audited financial statements for the period to 30 September 2021.
Aquis Stock Exchange (AQSE:LFT) Updated Application for Admission Announcement
ANNOUNCEMENT OF APPLICATION FOR ADMISSION TO THE AQSE GROWTH MARKET APPLICANT NAME: Lift Global Ventures Plc APPLICANT REGISTERED OFFICE, PRINCIPLE PLACE OF BUSINESS (IF DIFFERENT) AND TELEPHONE NUMBER: Address:
Nanosynth Group PLC (AIM:NNN) Response to shareholder enquiries
nanosynth group plc, the AIM quoted company, notes the recent enquiries from its shareholders and wishes to confirm that as stated in the announcement on 10 February 2022.
TPI provided its latest research note on DeepVerge plc (DVRG.L) & Microsaic Systems plc (MSYS.L).
News updates from both DeepVerge and Microsaic have been released this morning. While providing a trading update for its traditionally quiet first quarter, in which Q1 2022 produced record unaudited
Deepverge PLC (AIM:DVRG) Update; Manuf’g Service Agreement with Microsaic
Trading Update – Q1 2022 Sales up 84% to £2.38m (Q1 2021: £1.29m)
Deepverge PLC (AIM:DVRG) MoU with Abingdon Health for lateral flow tests
DeepVerge and Abingdon Health plc sign MoU for Commercial Agreement for Lateral Flow Tests in Modern Water Household Devices
